Background: Clinical and parasitological response of malaria treatment on day 3 follow-up (D3) is a crucial condition to predict the successful of treatment. D3 is a period time that Early Treatment Failure may happen which may cause severe or complicated malaria. Moreover, if the asexual parasitemia is still detected more than 10% study subjects, it is assumed parasites resistance against arte…
To obtain an alternative drug regimen to reduce the complications and mortality of malaria, a comparative clinical trial of artemether and quinine in severe and complicated falciparum malaria patients was carried out at Balikpapan General Hospital, East Kalimantan, Indonesia, in 1993-1995. The objective of this study was to assess and compare the efficacy and safety of intramuscular artemether …
Chloroquine resistant malaria is a serious problem in Indonesia especially in Irian Jaya. Artemether is a new antimalarial drug, reported to be very effective and safe in clinical studies. This drug is not yet available in Indonesia. To obtain an alternative antimalarial drug for the treatment of chloroquine resistant falciparum malaria cases, a trial of artemether treatment for uncomplicated f…